EPS

Orvana Minerals targets European investors at key conferences as it navigates widening losses and seeks to capitalize on strong commodity markets.

As NW Natural Holdings sets its Q1 2026 earnings call, investors watch to see if its diversification strategy can sustain last year's record growth.

As Black Diamond readies its Q1 2026 report, investors eye gains from a booming energy market and the strategic expansion of its LodgeLink platform.

As Crocs sets its Q1 earnings call, all eyes are on the struggling HEYDUDE brand, contrasting with the core brand's strong international performance.

As Watts Water Technologies preps its Q1 2026 report, investors watch for clues on market health, strategic growth, and the impact of new regulations.

ADP's latest dividend declaration highlights its financial strength and commitment to shareholders, cementing its status as a reliable income-generating stock.

The e-commerce giant's major vet clinic acquisition accelerates its plan to create an all-in-one ecosystem for pet parents, challenging industry titans.

As Cincinnati Financial preps its Q1 2026 results, we dive into the key metrics and industry trends that will define its performance and market reaction.

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.

As MasterBrand preps its Q1 2026 results, investors watch to see if cost cuts and new trends can counter a tough housing and renovation market.

As Molson Coors preps its Q1 2026 earnings call, all eyes are on its strategy to combat declining volumes and rising costs in a pivotal "reset year."

As Ryan Specialty preps its Q1 2026 results, investors watch to see if the firm can rebound from a tough quarter and navigate a complex insurance market.

The lender hits its highest rank on Fortune's Best Companies list, but does a celebrated internal culture translate to success in a challenging economy?

VanEck's new VEFA fund uses analyst upgrades to pick international stocks, aiming to capture returns as global markets gain on the concentrated US.

As IDEX Corp prepares its Q1 2026 report, investors watch to see if strength in its tech segment can offset mixed industrial market signals.

Expanded Medicare payment for RefleXion's SCINTIX therapy removes major financial hurdles, opening doors for advanced cancer care in community centers.

As Stryker preps its Q1 2026 report, all eyes are on whether the MedTech giant can sustain its momentum amid new products and industry-wide pressures.

Investors eye Alaska Air Group's Q1 results for insights on the Hawaiian Airlines integration, rising fuel costs, and shifting travel demand.

A new report reveals a huge gap between patient desires for holistic, less invasive fertility options and a system that defaults to costly IVF treatments.

Avory & Co. enters the crowded ETF market with AVRY, an actively managed fund shunning trends for a concentrated portfolio of high-quality stocks.